US FDA Would Get Mandatory Recall Authority For Drugs Under House Funding Bill
The change would let FDA forcibly pull prescription and over-the-counter drugs off the market just like vaccines, medical devices and other products.
You may also be interested in...
After two years of significant growth in non-user fee funds, House appropriators offer FDA a more modest increase for FY 2021.
US FDA officials grilled during first Senate Finance Committee hearing in months over practice of preannouncing foreign inspections.
Trump administration infuses Phlow with potentially $800m-plus for fully integrated domestic manufacture of essential medicines for COVID-19 and other crises. Key figures in new approaches to securing drugs and experts on China helped frame the project’s approach.